アデニンベースエディティングは,B型肝炎の表面抗原発現を強力に抑制し,D型肝炎ウイルスの放出を抑制します
bioRxiv : the preprint server for biology
|February 12, 2026
まとめ
アデニン塩基編集は,B型肝炎ウイルス (HBV) のDNA貯蔵庫をターゲットにすることで,B型肝炎ウイルス (HBV) の複製を妨害する新しい戦略を提供します. このアプローチは,HBV DNAおよびHBsAgの産生を in vitroおよびin vivoで減少させる大きな可能性を示しています.
科学分野:
- 分子生物学は分子生物学である.
- ウイルス学 ウイルス学 ウイルス学
- 遺伝子エディティング
背景:
- 肝臓内B型肝炎ウイルス (HBV) のDNA貯蔵庫を除去するには,コヴァラン性閉鎖円形DNA (cccDNA) と統合HBVDNAを含む新しい抗ウイルス戦略が必要である.
- アデニン塩基編集は,重複するHBs/ポリメラーゼのオープンリーディングフレーム (ORF) をターゲットにすることで,HBVの複製を妨害する潜在的な方法として調査されています.
研究 の 目的:
- HBVに対する治療戦略としてアデニン塩基編集 (ABE) を評価する.
- HBV複製を妨害し,ウイルスマーカーを減少させるABEの有効性を in vitroおよびin vivoで評価する.
- HBs ORFの編集が,D型肝炎ウイルス (HDV) の放出に与える影響を調査する.
主な方法:
- アデニン塩基エディター (ABE) とガイドRNA (gRNA) を設計し,HBs/ポリメラーゼORFに変異を導入しました.
- 同感染したABE mRNAおよびgRNAをHBV感染ヒト肝細胞および細胞系 (HepG2-hNTCP, HepG2.2.15, PLC/PRF/5) に同感染させた.
- 脂質ナノ粒子 (LNP) を利用し,HBV循環DNA変換およびHBV感染したヒト肝臓キメリックマウスの体内でABEおよびgRNAを投与した. 細胞ベースのモデルで評価されたHDV放出.
主要な成果:
- アデニン塩基編集は,ccccDNAと統合されたHBVDNAの両方をターゲットにすることで,HBsAgの生産とHBVの複製をインビトロで大幅に減少させた.
- 一回のLNP注射は,HBVcircleマウスでは検出不能のHBsAgをもたらし,2回の注射は,ヒトの肝臓キメリックマウスでは,血清HBsAgを90%減少させた.
- In vivo HBV DNAの複製は抑制され,HBs ORFの塩基編集は,in vitroでHDVの放出を著しく抑制しました.
結論:
- HBs ORFのアデニン塩基編集は,HBVの複製とHBsAgの生成を阻害する効果的な戦略です.
- このアプローチは,HBVとHDVの両方の感染症の治療の可能性を示しています.
- ベースエディティングは,持続的なHBV感染に対する新しい抗ウイルス療法を開発するための有望な道を提供します.
関連する概念動画
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System
6.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
250
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
250
RNA Editing
9.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.9K
Hepatic Drug Excretion: Influencing Factors
603
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
603
Hepatic Drug Clearance: Role of Transporters
311
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
311


